Analyst Research

Report Title Price
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Agfa-Gevaert NV's Agfa Healthcare Announces CR 10-X FDA Clearance and CR 10-X Availability in North America


Monday, 30 Jul 2012 08:00pm EDT 

Agfa-Gevaert NV announced that Agfa Healthcare's computed radiography (CR) solution, the CR 10-X has been FDA 510(k) cleared and is available throughout North America. This compact, table-top medical imaging digitizer provides small hospitals and practices an economical path from analog to digital solutions. 

Company Quote

2.225
0.018 +0.82%
11:35am EDT